Health ❯Research ❯Clinical Trials
Future Prospects Mitochondrial Medicine Alzheimer's Drug RI-AG03 Cancer Therapies Innovative Therapies Nitisinone Trials Gerontology Kinase Inhibitors
The preclinical success supports multiple ongoing LRRK2 inhibitor trials, suggesting that the approach could extend to non-genetic Parkinson’s.